Sector News

SRF acquires DuPont’s pharma propellant business Dymel for $20M

January 4, 2015
Energy & Chemical Value Chain
DuPont will supply SRF the product from its existing facility till SRF’s facility is approved.
 
Speciality chemicals firm SRF Ltd has acquired US-based E.l. DuPont De Nemours and Company (DuPont’s) pharma propellant business including the brand Dymel for $20 million (Rs 128 crore) in cash, as per a stock market disclosure.
 
Dymel provides a non-ozone depleting alternative propellant for use in the pharma industry. This business is part of the performance chemicals segment which DuPont anticipates separating by mid-2015.
 
Post acquisition, SRF will own DuPont’s ‘Dymel’ brand and receive the technology and know-how for setting up its own ‘current good manufacturing practices’ (cGMP) facility for manufacturing HFC 134a Pharma grade.
 
DuPont will supply SRF the product from its existing facility till SRF’s facility is approved.
 
“This acquisition is in sync with our long term strategy to move up the value chain and will enable us to enter the niche pharma product segment. The growth in the Metered Dose Inhalers (MDI) sector is expected to be reasonably robust in the years to come and with India playing a major role in this sector we are ideally positioned to take benefit of this opportunity. This will also offer great synergy with our existing HFC plants going forward,” said Ashish Bharat Ram, managing director of SRF.
 
“DuPont is making this move to enable a stronger focus on developing and commercializing the company’s new family of products. We believe this business is an excellent fit for SRF, which already supplies to the pharmaceutical industry,” said Kathryn K. McCord, global business director, DuPont Fluorochemicals.
 
Dymel also has applications in consumer and other industries. That line of the product is not part of this transaction.
 
Established in 1970, SRF is the one of the only Indian manufacturers of the grade of hydro fluoro carbon HFC 134a. For SRF, this transaction provides immediate access to DuPont’s technology, brand and customers, thus enabling an instant entry into the niche pharmaceutical segment at a global level.
 
SRF is engaged in the manufacture of chemical based industrial intermediates. Its business portfolio covers technical textiles, fluorochemicals, specialty chemicals, packaging films and engineering plastics. It has two plants for manufacture of technical grade of HFC 134a.
 
By Bhawna Gupta
 
Source: VC Circle

comments closed

Related News

January 19, 2025

Heraeus acquires Umicore’s platinum API business

Energy & Chemical Value Chain

Heraeus Precious Metals announced that it has acquired Umicore’s Platinum Active Pharmaceutical Ingredient (API) business outside of South America. This transaction is a unique opportunity for Heraeus to strengthen its position and product portfolio.

January 19, 2025

Celanese announces new leadership appointment to drive growth and profitability

Energy & Chemical Value Chain

Todd Elliott, a proven executive who retired from Celanese in 2020 as Senior Vice President (SVP) and head of the Acetyls business, will return to the Company as SVP to lead the Engineered Materials (EM) business, effective February 3, 2025.

January 19, 2025

Chemours announces Damián Gumpel as President of Titanium Technologies and Diane Picho as Chief Enterprise Enablement Officer

Energy & Chemical Value Chain

Damián Gumpel joins Chemours with deep chemical industry leadership experience. At the Olin Corporation, he most recently served as Vice President, Corporate Strategy, helping to define a new corporate strategy and executing a joint venture and several M&A transactions.

How can we help you?

We're easy to reach